I’m off for a few days of R&R but wanted to quickly recap some of the current medical design news, contract manufacturing expansions, the conversation on an extension of the EU MDR deadline that's fast approaching. Also, the August issue of Today’s Medical Developments is in the mail (hint: the digital edition is available to read today!)
Cirtec Medical to open 30,000 sq. ft. manufacturing facility in Costa Rica
Officials from Cirtec Medical Corp., a strategic outsourcing partner for complex medical devices, including active implantables and minimally invasive devices, announced construction began on a 30,000ft2 manufacturing facility in the Coyol free zone, located in Alajuela, Costa Rica.
The facility, which is expected to be fully operational by the end of the year, will be the company’s first venture into Latin America and is a result of Cirtec’s growth and the increased demand for high volume, cost-effective manufacturing. The facility will deliver expanded value-added manufacturing services such as neurostimulation leads, coil winding, and finished device assembly and packaging. The facility will include Class 7 and Class 8 cleanrooms and office space with additional room for future expansion. The operation will require hiring at least 40 local employees for the facility within the first year of operation.
Statement by the United States to the committee on technical barriers to trade – European Union – Medical Device Regulation (MDR) and in vitro Diagnostic Medical Devices Regulation (IVDR)
In a July 24, 2019 statement by the United States to the World Trade Organization Committee on Technical Barriers to Trade, officials urged “the EU to delay implementation by three years to allow for U.S. exporters to adapt to the new requirements,” stating as one concern that MDR/IVDR implementation is behind schedule. Read the full statement here.
A simulator mimics mechanical behavior of the torso and the engineers who created it hope it leads to innovations in the design of medical back supports.
5-year extension of collaborative research agreement aims to spur medical device innovation by enabling innovative, new product designs.